|
1
|
Moses SW: Historical highlights and
unsolved problems in glycogen storage disease type 1. Eur J
Pediatr. 161(Suppl 1): S2–S9. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Koeberl DD, Kishnani PS, Bali D and Chen
YT: Emerging therapies for glycogen storage disease type I. Trends
Endocrinol Metab. 20:252–258. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hutton JC and O'Brien RM:
Glucose-6-phosphatase catalytic subunit gene family. J Biol Chem.
284:29241–29245. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gu LL, Li XH, Han Y, Zhang DH, Gong QM and
Zhang XX: A novel homozygous no-stop mutation in G6PC gene from a
Chinese patient with glycogen storage disease type Ia. Gene.
536:362–365. 2014. View Article : Google Scholar
|
|
5
|
Resaz R, Vanni C, Segalerba D, Sementa AR,
Mastracci L, Grillo F, Murgia D, Bosco MC, Chou JY, Barbieri O, et
al: Development of hepatocellular adenomas and carcinomas in mice
with liver-specific G6Pase-α deficiency. Dis Model Mech.
7:1083–1091. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kishnani PS, Austin SL, Abdenur JE, Arn P,
Bali DS, Boney A, Chung WK, Dagli AI, Dale D, Koeberl D, et al:
Diagnosis and management of glycogen storage disease type I: A
practice guideline of the American college of medical genetics and
genomics. Genet Med. 16:e12014.PubMed/NCBI
|
|
7
|
Wang J, Cui H, Lee NC, Hwu WL, Chien YH,
Craigen WJ, Wong LJ and Zhang VW: Clinical application of massively
parallel sequencing in the molecular diagnosis of glycogen storage
diseases of genetically heterogeneous origin. Genet Med.
15:106–114. 2013. View Article : Google Scholar
|
|
8
|
Chou JY and Mansfield BC: Mutations in the
glucose-6-phosphatase-alpha (G6PC) gene that cause type Ia glycogen
storage disease. Hum Mutat. 29:921–930. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shieh JJ, Terzioglu M, Hiraiwa H, Marsh J,
Pan CJ, Chen LY and Chou JY: The molecular basis of glycogen
storage disease type 1a: Structure and function analysis of
mutations in glucose-6-phosphatase. J Biol Chem. 277:5047–5053.
2002. View Article : Google Scholar
|
|
10
|
Chou JY, Jun HS and Mansfield BC: Glycogen
storage disease type I and G6Pase-β deficiency: Etiology and
therapy. Nat Rev Endocrinol. 6:676–688. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li DZ, Liao C and Tang XW: Prenatal
diagnosis of glycogen storage disease type Ia, presenting a new
mutation in the glucose-6-phosphatase gene. Prenat Diagn.
27:685–686. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shah KK and O'Dell SD: Effect of dietary
interventions in the maintenance of normoglycaemia in glycogen
storage disease type 1a: A systematic review and meta-analysis. J
Hum Nutr Diet. 26:329–339. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Belingheri M, Ghio L, Sala A, Menni F,
Trespidi L, Ferraresso M, Berardinelli L, Rossi G, Edefonti A and
Parini R: Combined liver-kidney transplantation in glycogen storage
disease Ia: A case beyond the guidelines. Liver Transpl.
13:762–764. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Marega A, Fregonese C, Tulissi P, Vallone
C, Gropuzzo M, Toniutto PL, Baccarani U, Bresadola F, Toso F and
Montanaro D: Preemptive liver-kidney transplantation in von Gierke
disease: A case report. Transplant Proc. 43:1196–1197. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yiu WH, Lee YM, Peng WT, Pan CJ, Mead PA,
Mansfield BC and Chou JY: Complete normalization of hepatic G6PC
deficiency in murine glycogen storage disease type Ia using gene
therapy. Mol Ther. 18:1076–1084. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee YM, Jun HS, Pan CJ, Lin SR, Wilson LH,
Mansfield BC and Chou JY: Prevention of hepatocellular adenoma and
correction of metabolic abnormalities in murine glycogen storage
disease type Ia by gene therapy. Hepatology. 56:1719–1729. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee YM, Pan CJ, Koeberl DD, Mansfield BC
and Chou JY: The upstream enhancer elements of the G6PC promoter
are critical for optimal G6PC expression in murine glycogen storage
disease type Ia. Mol Genet Metab. 110:275–280. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Clar J, Mutel E, Gri B, Creneguy A,
Stefanutti A, Gaillard S, Ferry N, Beuf O, Mithieux G, Nguyen TH
and Rajas F: Hepatic lentiviral gene transfer prevents the
long-term onset of hepatic tumours of glycogen storage disease type
1a in mice. Hum Mol Genet. 24:2287–2296. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Resaz R, Emionite L, Vanni C, Astigiano S,
Puppo M, Lavieri R, Segalerba D, Pezzolo A, Bosco MC, Oberto A, et
al: Treatment of newborn G6pc(-/-) mice with bone marrow-derived
myelomonocytes induces liver repair. J Hepatol. 55:1263–1271. 2011.
View Article : Google Scholar : PubMed/NCBI
|
